Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04892719 · ClinicalTrials.gov registry record · NA
4DX Functional Lung Imaging in the Diagnosis of Chronic Lung Allograft Dysfunction After Lung Transplantation
A NA study, sponsored by Duke University.
- Completed
- Registry status
- NA
- Development phase
- 18
- Enrollment target
NCT04892719 is a NA study that has completed, run by Duke University. The registered enrollment target is 18 participants.
The verdict
NCT04892719, a NA study, has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- NA
- Development phase
- 18 participants
- Enrollment target
Study Summary
This is a pilot study to determine the utility of Novel Functional Lung Imaging and Ventilation (4DxV) Analysis software in measurement of lung ventilation abnormalities and diagnosis of chronic lung allograft dysfunction (CLAD) after lung transplantation.
Interventions
- DIAGNOSTIC_TEST Fluoroscopic chest imaging with 4Dx technology software analysis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2020-10-28 |
| Est. Completion | 2022-03-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04892719
The ClinicalTrials.gov registry entry for NCT04892719 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 18 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Fluoroscopic chest imaging with 4Dx technology software analysis is the first listed.
NCT04892719 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04892719 about?
NCT04892719 is a clinical study titled "4DX Functional Lung Imaging in the Diagnosis of Chronic Lung Allograft Dysfunction After Lung Transplantation". This is a pilot study to determine the utility of Novel Functional Lung Imaging and Ventilation (4DxV) Analysis software in measurement of lung ventilation abnormalities and diagnosis of chronic lung allograft dysfunction (CLAD) after lung transplantation.
What is the current status of trial NCT04892719?
This trial is currently completed. It is a NA study. The enrollment target is 18 participants. The study started on 2020-10-28. Estimated completion is 2022-03-31.
What interventions are being tested in trial NCT04892719?
The interventions under investigation include: Fluoroscopic chest imaging with 4Dx technology software analysis (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT04892719?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.